Evidence map›Paper›PMID 41438976›Full record

ArticleEClinicalMedicine2025

The 3V score and joint associations of low ultra-processed food, biodiverse and plant-based diets on colorectal cancer risk: results from the European Prospective Investigation into Cancer and Nutrition (EPIC) study.

Emine Koc Cakmak, Aline Al Nahas, Bernadette Chimera, Giles Hanley-Cook, Jeroen Berden, Anthony Fardet, Edmond Rock, Carine Biessy, Geneviève Nicolas, Nathalie Kliemann and 35 more

Erratum issuedAbstract read
In one paragraph

Article in EClinicalMedicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. An erratum has been issued. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Review
4 · The record

Corrections and comments

5 · Who and what money

Authors and funding

45 authors.

Emine Koc CakmakDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Aline Al NahasNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Bernadette ChimeraNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Giles Hanley-CookDepartment of Food Technology, Safety and Health, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Jeroen BerdenNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Anthony FardetINRAE, Université Clermont Auvergne, UNH, Human Nutrition Unit, CRNH Auvergne, F-63000, Clermont-Ferrand, France.
Edmond RockINRAE, Université Clermont Auvergne, UNH, Human Nutrition Unit, CRNH Auvergne, F-63000, Clermont-Ferrand, France.
Carine BiessyNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Geneviève NicolasNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Nathalie KliemannCentro de Pesquisas Oncológicas (CEPON), Santa Catarina, Brazil.
Fernanda RauberCenter for Epidemiological Research in Nutrition and Health, University of São Paulo, Av. Dr Arnaldo 715, São Paulo, SP, 01246-904, Brazil.
Renata Bertazzi LevyCenter for Epidemiological Research in Nutrition and Health, University of São Paulo, Av. Dr Arnaldo 715, São Paulo, SP, 01246-904, Brazil.
Lorenzo MangoneDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Mathilde TouvierUniversité Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Centre of Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN), F-93017, Bobigny, France.
Bernard SrourUniversité Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Centre of Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN), F-93017, Bobigny, France.
Emmanuelle Kesse-GuyotUniversité Sorbonne Paris Nord and Université Paris Cité, INSERM, INRAE, CNAM, Centre of Research in Epidemiology and StatisticS (CRESS), Nutritional Epidemiology Research Team (EREN), F-93017, Bobigny, France.
Carl LachatDepartment of Food Technology, Safety and Health, Faculty of Bioscience Engineering, Ghent University, Ghent, Belgium.
Guri SkeieDepartment of Community Medicine, UIT The Arctic University of Norway, Tromsø, Norway.
Elisabete WeiderpassInternational Agency for Research on Cancer, Lyon, France.
Franziska JannaschDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur Scheunert-Allee 114 -116, 14558, Nuthetal, Germany.
Christina C DahmDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Daniel Borch IbsenDepartment of Public Health, Aarhus University, Aarhus, Denmark.
Christina DahlDiet, Cancer and Health, Danish Cancer Institute, Copenhagen, Denmark.
Cecilie KyrøDiet, Cancer and Health, Danish Cancer Institute, Copenhagen, Denmark.
Mariem Hajji-LouatiParis-Saclay University, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
Chloé MarquesParis-Saclay University, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
Gianluca SeveriParis-Saclay University, UVSQ, Inserm, Gustave Roussy, CESP, Villejuif, France.
Verena KatzkeDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Rudolf KaaksDivision of Cancer Epidemiology, German Cancer Research Center (DKFZ), Heidelberg, Germany.
Matthias B SchulzeDepartment of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbruecke, Arthur Scheunert-Allee 114 -116, 14558, Nuthetal, Germany.
Saverio CainiCancer Risk Factors and Lifestyle Epidemiology Unit, Institute for Cancer Research, Prevention, and Clinical Network (ISPRO), Florence, Italy.
Sabina SieriEpidemiology and Prevention Unit, Fondazione IRCCS Istituto Nazionale Dei Tumori Di Milano, Milan, Italy.
Maria Santucci De MagistrisDepartment of Clinical and Experimental Medicine, Federico II University, Naples, Italy.
Rosario TuminoHyblean Association for Epidemiology Research AIRE ONLUS Ragusa, Italy.
Carlotta SacerdoteDepartment of Health Sciences, University of Eastern Piedmont, Via Solaroli 17, 28100, Novara, Italy.
Raúl Zamora-RosUnit of Nutrition and Cancer, Cancer Epidemiology Research Program, Catalan Institute of Oncology, Bellvitge Biomedical Research Institute (IDIBELL), Barcelona, Spain.
Maria-José SánchezEscuela Andaluza de Salud Pública (EASP), 18011, Granada, Spain.
Ana Jimenez-ZabalaMinistry of Health of the Basque Government, Sub-Directorate for Public Health and Addictions of Gipuzkoa, San Sebastián, Gipuzkoa, Spain.
Jesús-Humberto GómezDepartment of Epidemiology, Regional Health Council, IMIB-Arrixaca, Murcia, Spain.
Marcela GuevaraInstituto de Salud Pública y Laboral de Navarra, 31003, Pamplona, Spain.
Elio RiboliDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Marc J GunterDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Inge HuybrechtsNutrition and Metabolism Branch, International Agency for Research on Cancer, Lyon, France.
Paolo VineisDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.
Oliver J K RobinsonDepartment of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, United Kingdom.

Funding

Ceramides as novel drivers of metabolic dysfunction and colorectal cancerU01CA272529 · NCI · UTAH STATE HIGHER EDUCATION SYSTEM--UNIVERSITY OF UTAH · PI Mary Christine Playdon, SCOTT A SUMMERS · 2022 to 2026
$4.7M
NCI NIH HHS U01 CA272529World Health Organization 001
6 · The paper itself

Abstract

Background: Diet may modify colorectal cancer risk. We investigated the associations of three dietary patterns, ultra-processed food (UPF) consumption, healthy plant-based food consumption, and food biodiversity, separately and combined into a "3V" score with risk of colorectal cancer. Methods: This study used data from the prospective European Prospective Investigation into Cancer and Nutrition (EPIC) cohort, which recruited participants between 1992, and 2000, from 23 centres in ten European countries. The 3V score was developed by standardising and summing the healthy plant diet index (hPDI) and dietary species richness per year (DSR) and subtracting UPF (Nova category 4) intake in % g/day. Associations with colorectal cancer risk were assessed among 450,111 middle-aged participants of the EPIC cohort using multivariable-adjusted Cox regression models. Independent associations of each 3V component were assessed using mutually adjusted models. Data-driven thresholds were applied to assess adherence to the 3V components, set at the minimum value of the fourth quintile for hPDI, DSR and low UPF. Findings: During mean (standard deviation (SD)) follow-up of 14.9 (4) years, absolute colorectal cancer rates were 8.59 and 10.37 cases/10,000 person-years for the highest and lowest quintiles of the 3V score, respectively. Inverse associations were found for colorectal (hazard ratio (HR) comparing highest vs lowest quintile: 0.84; 95% confidence interval (CI): 0.76-0.94), colon (HR: 0.82; 95% CI: 0.72-0.93), and distal colon cancer (HR: 0.81; 95% CI: 0.67-0.99), with significant linear trends observed across quintiles. UPF intake was positively associated with colon cancer risk (HR per 1 SD increment: 1.06; 95% CI: 1.02-1.11) when mutually adjusted for the other 3V components. Adherence to low UPF, high hPDI, and high DSR was inversely associated with colorectal (HR: 0.73; 95% CI: 0.61-0.88), colon (HR: 0.72; 95% CI: 0.57-0.91), and rectal cancer (HR: 0.65; 95% CI: 0.46-0.91) compared to adhering to none. Interpretation: Adherence to the 3V diet is associated with lower risk of colorectal cancers. Funding: Cancer Research UK, World Cancer Research Fund.

Indexed as

Colorectal cancerDietary risk factorsFood biodiversityFood processingProspective cohort

Identifiers

PMID41438976
PMCPMC12719066

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.